BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31043775)

  • 1. Reproducibility of fluid-phase measurements in PBS-treated sputum supernatant of healthy and stable COPD subjects.
    Wang F; Liang Z; Yang Y; Zhou L; Guan L; Wu W; Jiang M; Shi W; Deng K; Chen J; Chen R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():835-852. PubMed ID: 31043775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD.
    Beeh KM; Beier J; Kornmann O; Mander A; Buhl R
    Chest; 2003 Mar; 123(3):778-83. PubMed ID: 12628878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of sputum and serum autoantibodies in patients with chronic obstructive pulmonary disease.
    Cass SP; Dvorkin-Gheva A; Yang Y; McGrath JJC; Thayaparan D; Xiao J; Wang F; Mukherjee M; Long F; Peng T; Nair P; Liang Z; Stevenson CS; Li QZ; Chen R; Stampfli MR
    Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1169-L1182. PubMed ID: 33908260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.
    Tangedal S; Aanerud M; Persson LJ; Brokstad KA; Bakke PS; Eagan TM
    Respir Res; 2014 Nov; 15(1):138. PubMed ID: 25398249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Circulating Autoantibodies Levels of IgG, IgA, IgM Against Cytokeratin 18 and Cytokeratin 19 in Chronic Obstructive Pulmonary Disease.
    Xiong Y; Gao S; Luo G; Cheng G; Huang W; Jiang R; Wang Y; Cui T
    Arch Med Res; 2017 Jan; 48(1):79-87. PubMed ID: 28577873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease.
    Shindi R; Almehairi A; Negm OH; Kalsheker N; Gale NS; Shale DJ; Harrison TW; Bolton CE; John M; Todd I; Tighe PJ; Fairclough LC
    Clin Immunol; 2017 Oct; 183():344-353. PubMed ID: 28951328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies of IgG, IgA and IgM against Human Bronchial Epithelial Cell in Patients with Chronic Obstructive Pulmonary Disease.
    Cheng G; Zhang N; Wang Y; Rui J; Yin X; Cui T
    Clin Lab; 2016; 62(6):1101-8. PubMed ID: 27468572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum and serum autoantibody profiles and their clinical correlation patterns in COPD patients with and without eosinophilic airway inflammation.
    Liang Z; Wang F; Zhang D; Long F; Yang Y; Gu W; Deng K; Xu J; Jian W; Zhou L; Shi W; Zheng J; Chen X; Chen R
    J Thorac Dis; 2020 Jun; 12(6):3085-3100. PubMed ID: 32642231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.
    Pizzichini E; Pizzichini MM; Efthimiadis A; Evans S; Morris MM; Squillace D; Gleich GJ; Dolovich J; Hargreave FE
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):308-17. PubMed ID: 8756799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
    Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
    Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma.
    in 't Veen JC; de Gouw HW; Smits HH; Sont JK; Hiemstra PS; Sterk PJ; Bel EH
    Eur Respir J; 1996 Dec; 9(12):2441-7. PubMed ID: 8980951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.
    Röpcke S; Holz O; Lauer G; Müller M; Rittinghausen S; Ernst P; Lahu G; Elmlinger M; Krug N; Hohlfeld JM
    PLoS One; 2012; 7(10):e46207. PubMed ID: 23056262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methods.
    Metso T; Rytilä P; Peterson C; Haahtela T
    Respir Med; 2001 Jan; 95(1):48-55. PubMed ID: 11207017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.
    Rutgers SR; van der Mark TW; Coers W; Moshage H; Timens W; Kauffman HF; Koëter GH; Postma DS
    Thorax; 1999 Jul; 54(7):576-80. PubMed ID: 10377200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers.
    Ma A; Wen L; Yin J; Hu Y; Yue X; Li J; Dong X; Gupta Y; Ludwig RJ; Krauss-Etschmann S; Riemekasten G; Petersen F; Yu X
    Int J Chron Obstruct Pulmon Dis; 2020; 15():189-200. PubMed ID: 32099344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between airway and systemic autoantibody responses in chronic obstructive pulmonary disease.
    Liang Z; Long F; Deng K; Wang F; Xiao J; Yang Y; Zhang D; Gu W; Xu J; Jian W; Shi W; Zheng J; Chen X; Gao Y; Luo Q; Stampfli MR; Peng T; Chen R
    Ann Transl Med; 2020 Aug; 8(15):918. PubMed ID: 32953718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
    Keatings VM; Collins PD; Scott DM; Barnes PJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles.
    Liang Z; Long F; Wang F; Yang Y; Xiao J; Deng K; Gu W; Zhou L; Xie J; Jian W; Chen X; Jiang M; Zheng J; Peng T; Chen R
    Mol Med Rep; 2019 Sep; 20(3):2882-2892. PubMed ID: 31322204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD.
    Rutgers SR; Timens W; Kaufmann HF; van der Mark TW; Koëter GH; Postma DS
    Eur Respir J; 2000 Jan; 15(1):109-15. PubMed ID: 10678630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.